| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 27, 2022 | Dec 29, 2022 | TScan Therapeutics, Inc. | CFO | Buy | 90.0 | +6,000 | 22.32% | ✗ | $9.2K |
| Mar 24, 2022 | Mar 28, 2022 | TScan Therapeutics, Inc. | CFO | Buy | 95.0 | +15,000 | 126.21% | ✗ | $51K |
| Sep 21, 2021 | Sep 22, 2021 | TScan Therapeutics, Inc. | CFO | Buy | 91.3 | +5,000 | 72.62% | ✗ | $31.6K |
| Sep 9, 2021 | Sep 13, 2021 | TScan Therapeutics, Inc. | CFO | Buy | 91.3 | +5,885 | 588.50% | ✗ | $49.9K |
| Jul 20, 2021 | Jul 22, 2021 | TScan Therapeutics, Inc. | CFO | Buy | 91.3 | +1,000 | 100.00% | ✗ | $15K |